Role of pioglitazone treatment on atrial remodeling and atrial fibrillation (AF)promotion in an experimental model of congestive heart failure

Heart Rhythm. 2008 Apr;5(4):636; author reply 636-7. doi: 10.1016/j.hrthm.2008.01.037. Epub 2008 Jan 29.

Authors

Panagiotis Korantzopoulos, John A Goudevenos, Tong Liu, Guangping Li

PMID: 18362032
DOI: 10.1016/j.hrthm.2008.01.037

No abstract available

Publication types

Letter
Comment

MeSH terms

Angiotensin II Type 1 Receptor Blockers / pharmacology
Animals
Atrial Fibrillation / drug therapy*
Atrial Fibrillation / pathology
Disease Models, Animal
Heart Atria / drug effects*
Heart Atria / pathology
Heart Failure / chemically induced*
Heart Failure / physiopathology
Hypoglycemic Agents / adverse effects
Inflammation
Oxidative Stress
Pioglitazone
Rabbits
Thiazolidinediones / adverse effects*
Thiazolidinediones / pharmacology
Thiazolidinediones / therapeutic use

Substances

Angiotensin II Type 1 Receptor Blockers
Hypoglycemic Agents
Thiazolidinediones
Pioglitazone